For instance, a BCR-ABL1-like B-ALL subtype was described that shows a gene expression profile and a therapeutic vulnerability similar to BCR-ABL1 patients, despite not presenting the BCR-ABL1 fusion (13). Here, ABL1 is linked to acute lymphoblastic leukemia.